US mutual insurers report a sharp underwriting turnaround
The 2025 results call for a careful split between pricing discipline and favourable weather
In September 2026, AM Best reported that its rated US property and casualty mutual composite earned a $14.8 billion underwriting gain in 2025, compared with a $7.2 billion loss in 2024. Net income doubled to $42.6 billion and policyholders’ surplus rose to $468 billion. These are 2025 financial results published on September 24, 2026.
Earlier rate increases, revised discounts and higher deductibles contributed, according to AM Best. So did improved analytical tools. A quiet Atlantic hurricane season helped, although other weather losses persisted. The reported turnaround is real for the composite, but the headline does not isolate durable underwriting improvement from favourable catastrophe experience and portfolio mix.
Boards should examine accident-year results, reserve development, achieved versus needed rate, loss-cost trends and a scenario with heavier catastrophe losses. Liability lines require separate scrutiny because social inflation can outlast a property-market recovery. Stronger surplus may support policyholder dividends or a different reinsurance retention, but neither follows automatically from one good year.
For benefits insurers and pooling networks, the transferable lesson is to separate the drivers of earnings in board reporting; the US property and casualty figures do not describe medical or group life portfolios. A mutual’s duty to policyholders is best served by showing how today’s distribution and reinsurance decisions would perform across several less favourable years.
The policyholder dividend decision is especially important: early 2026 distributions were higher than a year earlier, but reserves and catastrophe capital must still withstand a poor year. A board can link dividends to a capital corridor and stress tests. Smaller mutuals may have close local risk knowledge yet less geographic spread; comparing their loss ratios requires that distinction.


No Comment